Dr. Nicoletta Colombo breaks down KEYNOTE B96 showing Keytruda plus paclitaxel, with or without Avastin, improves survival in platinum-resistant ovarian cancer. The phase 3 KEYNOTE B96 trial showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results